- Home
- WSBCP vs IDYA Comparison
WSBCP vs IDYA Comparison
Compare WSBCP & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBCP
- IDYA
- Stock Information
- Founded
- WSBCP N/A
- IDYA 2015
- Country
- WSBCP United States
- IDYA United States
- Employees
- WSBCP 2195
- IDYA N/A
- Industry
- WSBCP Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- WSBCP Finance
- IDYA Health Care
- Exchange
- WSBCP Nasdaq
- IDYA Nasdaq
- Market Cap
- WSBCP N/A
- IDYA 1.9B
- IPO Year
- WSBCP N/A
- IDYA 2019
- Fundamental
- Price
- WSBCP $25.31
- IDYA $22.10
- Analyst Decision
- WSBCP
- IDYA Strong Buy
- Analyst Count
- WSBCP 0
- IDYA 13
- Target Price
- WSBCP N/A
- IDYA $53.42
- AVG Volume (30 Days)
- WSBCP N/A
- IDYA 1.0M
- Earning Date
- WSBCP N/A
- IDYA 08-05-2025
- Dividend Yield
- WSBCP N/A
- IDYA N/A
- EPS Growth
- WSBCP N/A
- IDYA N/A
- EPS
- WSBCP N/A
- IDYA N/A
- Revenue
- WSBCP N/A
- IDYA $7,000,000.00
- Revenue This Year
- WSBCP N/A
- IDYA $101.20
- Revenue Next Year
- WSBCP N/A
- IDYA $286.70
- P/E Ratio
- WSBCP N/A
- IDYA N/A
- Revenue Growth
- WSBCP N/A
- IDYA N/A
- 52 Week Low
- WSBCP N/A
- IDYA $13.45
- 52 Week High
- WSBCP N/A
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- WSBCP 61.66
- IDYA 58.95
- Support Level
- WSBCP $25.25
- IDYA $20.50
- Resistance Level
- WSBCP $25.24
- IDYA $22.27
- Average True Range (ATR)
- WSBCP 0.04
- IDYA 0.94
- MACD
- WSBCP 0.01
- IDYA -0.13
- Stochastic Oscillator
- WSBCP 77.78
- IDYA 70.88
About WSBCP WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.